My Size CEO Ronen Luzon Amends Ownership Filing

TL;DR

**My Size CEO Ronen Luzon just updated his ownership stake in the company.**

AI Summary

Ronen Luzon, CEO of My Size, Inc., filed an SC 13D/A on February 16, 2024, amending his previous Schedule 13D. The filing indicates a change in his beneficial ownership of My Size, Inc. Common Stock, par value $0.001 per share, as of the event date of February 14, 2024. This amendment updates information regarding his holdings in the company, which is headquartered in Airport City, Israel.

Why It Matters

This filing provides updated transparency on the beneficial ownership of My Size, Inc.'s CEO, which can influence investor perception and company control dynamics.

Risk Assessment

Risk Level: low — This is an informational filing about a change in beneficial ownership, not an event that inherently carries high risk.

Key Players & Entities

• Ronen Luzon (person) — Filing Person, CEO of My Size, Inc.
• My Size, Inc. (company) — Subject Company, Issuer
• 06 Technology (company) — Organization Name (associated with subject company data)
• Or Kles (person) — Contact for copies
• February 14, 2024 (date) — Date of Event Requiring Filing
• $0.001 (dollar_amount) — Par value per share of Common Stock

FAQ

Key Financial Figures

• $0.001 — Inc. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class o
• $0.6838 — ld 4,683 Shares at a price per share of $0.6838 pursuant to a Rule 10b5-1 trading plan

Filing Documents

• formsc13da.htm (SC 13D/A) — 81KB
• ex-b.htm (EX-1) — 61KB
• 0001493152-24-007023.txt ( ) — 144KB

to Schedule 13D

Item 4 to Schedule 13D. From time to time, each Reporting Person may also acquire beneficial ownership of additional Shares or other securities of the Issuer as compensation from the Issuer, by purchase or otherwise, including, including, but not limited to, awards of restricted Shares, options to purchase Shares, and restricted stock units for Shares, or dispose of some or all of the Shares beneficially owned by such Reporting Person in the open market or in privately negotiated transactions (which may be with the Issuer or with third parties) on such terms and at such times as such Reporting Person may deem advisable. Item 5. Interest in Securities of the Issuer (a) – (b) The information contained in rows 7, 8, 9, 10, 11 and 13 on the cover pages of this Schedule 13D (including the footnotes thereto) is incorporated by reference herein. (c) No transactions in the Issuer’s Shares were effected during the past 60 days by the Reporting Person except as set forth in Item 3 above. (d) Not applicable. (e) Not applicable. Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed as Exhibit A to the Schedule 13D filed by the Reporting Persons with the SEC on November 21, 2022, pursuant to which the Reporting Persons agreed to file such Schedule 13D and any amendments thereto jointly in accordance with the provisions of Rule 13d-1(k)(1) of the Securities Exchange Act of 1934, as amended. Item 7. Material to Be Filed as Exhibits Exhibit A Joint Filing Agreement, dated as of October 31, 2022 (incorporated by reference to Exhibit A to the Schedule 13D filed by the Reporting Persons on November 21, 2022) Exhibit B Form of Section 102 Capital Gain Restricted Stock Award Agreement under the My Size, Inc. 2017 Equity Incentive Plan Page 6 Signature After reasonable inquiry and to the best of my knowledge

View Full Filing

View this SC 13D/A filing on SEC EDGAR